Male N (%) | Female N (%) | χ 2 (1) | Preclinical N (%) | Clinical N (%) | χ 2 (1) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
It had no effect on me | |||||||||||
Clinical | 79 | (66.9) | 101 | (45.1) | 14.81** | male | 79 | (66.9) | 67 | (57.3) | ns. |
Pre-clinical | 67 | (57.3) | 82 | (32.7) | 20.04** | female | 101 | (45.1) | 82 | (32.7) | 7.71* |
I often thought about it afterwards | |||||||||||
Clinical | 28 | (23.7) | 71 | (31.7) | ns. | male | 28 | (23.7) | 27 | (23.1) | ns. |
Pre-clinical | 27 | (23.1) | 112 | (44.6) | 15.76** | female | 71 | (31.7) | 112 | (44.6) | 8.35* |
I had daytime flashbacks of it | |||||||||||
Clinical | 17 | (14.4) | 50 | (22.3) | ns. | male | 17 | (14.4) | 19 | (16.2) | ns. |
Pre-clinical | 19 | (16.2) | 81 | (32.3) | 10.36* | female | 50 | (22.3) | 81 | (32.3) | 5.87* |